Abstract
The relationship between c-erbB-2 gene expression (assessed immunohistochemically), S-phase fraction (SPF) and prognosis has been analysed in 172 women with primary breast cancer. c-erbB-2 staining was independent of age, tumour size, number of nodes involved, tumour grade and DNA ploidy, but was more common in oestrogen receptor (ER) negative tumours (P = 0.02) and progesterone receptor (PgR) negative tumours (P = 0.03). A weak correlation between c-erbB-2 staining and SPF was observed (r = 0.18). Amongst women with node negative disease, SPF was significantly related to relapse free survival (RFS, P = 0.04) while c-erbB-2 staining was not (P = 0.2). In contrast, both SPF (P = 0.002) and c-erbB-2 staining (P = 0.016) provided significant prognostic information on RFS for women with node positive disease. Multivariate analysis showed that c-erbB-2 staining and SPF gave independent information on RFS for women with node positive disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O'Reilly, S., Barnes, D., Camplejohn, R. et al. The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer. Br J Cancer 63, 444–446 (1991). https://doi.org/10.1038/bjc.1991.102
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.102
This article is cited by
-
A careful reassessment of anthracycline use in curable breast cancer
npj Breast Cancer (2021)
-
The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer
Cancer Immunology, Immunotherapy (2018)
-
HER2/neu in systemic therapy for women with breast cancer: a systematic review
Breast Cancer Research and Treatment (2008)
-
Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma
British Journal of Cancer (2004)
-
Breast and prostate cancer
Indian Journal of Clinical Biochemistry (2000)